HHTM

A recent cohort study published today in JAMA Network Open has revealed significant findings on the prevalence of vestibular impairment in children with bilateral profound hearing loss (HL) and its association with developmental delays. Conducted by Dr. Sylvette R. Wiener-Vacher and her colleagues at a pediatric referral center in Paris, France, the study underscores the critical need for comprehensive vestibular

MONTPELLIER, FRANCE – Cilcare, a clinical-stage biotechnology company specializing in auditory sciences and the development of novel therapies for inner ear diseases, has announced the appointment of Dr. Naimi Missoum as Chief Medical Officer. Dr. Missoum, a Medical Doctor with over 25 years of experience as a senior executive in medical affairs at leading pharmaceutical companies, will oversee all of

There exists a significant disparity between the number of individuals in need of hearing aids and those who actually utilize them. This discrepancy may stem from instances where users have encountered dissatisfaction with their hearing aids. Several factors contribute to hearing aid satisfaction, with poor fitting sessions being a notable concern. Given the uniqueness of each individual’s ears, precise measurements

Ear Science Institute Australia has secured Future Health Research & Innovation (FHRI) funding to establish a Western Australia-headquartered Australasian biobank, aimed at advancing genetic therapies for childhood and adult hearing loss. The Australasian Hearing Registry and Biobank (AHRB) will be the first in Australia to store tissue related to genetic-associated hearing loss, with the goal of advancing personalized care and

Join us for an insightful panel discussion from the 2024 Future of Hearing Healthcare Conference, moderated by Dave Kemp. The panel features four entrepreneurial audiologists: Brandi Smiley, Kathleen Wallace, Amanda Levy, and Melanie Hecker. Dr. Brandi Smiley will share her journey from traditional healthcare to mobilizing audiology services in a “tiny house” clinic in Georgia. Dr. Kathleen Wallace will discuss

SYDNEY, AUSTRALIA — Cochlear Limited, a global leader in implantable hearing solutions, has announced the completion of its acquisition of the Oticon Medical cochlear implant business from Demant. The acquisition follows Demant’s decision to discontinue its efforts in hearing implants, and the transaction was completed at a zero headline purchase price with all required conditions satisfied. “We welcome Oticon Medical’s

Amanda Philpott, Co-founder and CEO of eargym sat down with Brian Taylor to discuss the eargym app. The app includes a self-guided hearing loss check feature along with training exercises that target five core auditory processing skills — all packaged in a fun and engaging way. Amanda also reviews the science behind the subscription-based eargym, and the role the app

ITASCA, ILLINOIS — Knowles Corporation (NYSE: KN), a market leader and global provider of advanced micro-acoustic microphones and speakers, audio solutions, and high-performance capacitors and RF products, today announced consumer audio brand Meizu has selected Knowles balanced armature (BA) drivers and SiSonic™ high-performance MEMS microphones to produce premium sound for the new LIVE AI Noise Cancelling Hi-Fi Earbuds. Meizu LIVE AI Noise Cancelling Hi-Fi Earbuds deliver

SEATTLE & INNSBRUCK, AUSTRIA — Sound Pharmaceuticals (SPI) has announced that it has received FDA notification that its Investigational New Drug Application (IND) may proceed involving SPI-1005 treatment and cochlear implantation (CI). The goal of this Phase 2 SPI-1005 (ebselen) trial is to reduce the loss of residual hearing during and after CI. Ebselen is a novel anti-inflammatory compound that

Click here to read the May 2024 NeuroAudiology Newsletter.